SUSMED, Inc. (TOKYO:4263) announced that "SUSMED SourceDataSync®" ("SUSMED SDS"), its proprietary blockchain-based clinical trial system, has contributed to obtaining marketing authorization for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results